Hyponatremia in Acute Decompensated Heart Failure: Mechanisms, Prognosis, and Treatment Options (Q37810828)

23 August 2017

3 references

4 July 2020

5 July 2020

4 September 2020

Hyponatremia in acute decompensated heart failure: mechanisms, prognosis, and treatment options (English)

1 reference

https://api.crossref.org/works/10.1002/CLC.20822

23 August 2017

Hyponatremia in Acute Decompensated Heart Failure: Mechanisms, Prognosis, and Treatment Options (English)

1 reference

30 August 2024

1 reference

4 September 2020

1 reference

4 July 2020

3 references

4 July 2020

5 July 2020

4 September 2020

antidiuretic hormone receptor antagonists

1 reference

5 July 2020

1 reference

4 September 2020

acute decompensated heart failure

1 reference

Geoffrey T. Jao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21089110

30 August 2024

Jun R. Chiong

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21089110

30 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21089110

30 August 2024

publication date

1 November 2010

4 references

full work available at URL

23 August 2017

4 July 2020

5 July 2020

4 September 2020

https://europepmc.org/articles/pmc6653540?pdf=render

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21089110

https://europepmc.org/articles/PMC6653540

30 August 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21089110

https://europepmc.org/articles/PMC6653540?pdf=render

30 August 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21089110

https://doi.org/10.1002/clc.20822

30 August 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21089110

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002/clc.20822

30 August 2024

1 reference

https://api.crossref.org/works/10.1002/CLC.20822

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clc.20822

30 August 2024

1 reference

https://api.crossref.org/works/10.1002/CLC.20822

30 August 2024

4 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653540&resulttype=core&format=json

15 May 2020

4 July 2020

5 July 2020

4 September 2020

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653540&resulttype=core&format=json

15 May 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653540&resulttype=core&format=json

15 May 2020

page(s)

666-671

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653540&resulttype=core&format=json

15 May 2020

1 reference

12 December 2020

Nonosmolar factors affecting renal water excretion (second of two parts)

1 reference

12 December 2020

Antidiuretic hormone. Normal and disordered function

1 reference

12 December 2020

Gibbs memorial lecture. Unifying hypothesis of body fluid volume regulation: implications for cardiac failure and cirrhosis

1 reference

12 December 2020

Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure

1 reference

12 December 2020

Systemic diseases associated with disorders of water homeostasis

1 reference

12 December 2020

Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.

1 reference

12 December 2020

Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial

1 reference

12 December 2020

Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model

1 reference

12 December 2020

Hyponatremia in congestive heart failure

1 reference

12 December 2020

Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-

1 reference

12 December 2020

Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits

1 reference

12 December 2020

Hyponatremia and heart failure--treatment considerations

1 reference

12 December 2020

Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium

1 reference

12 December 2020

Sodium and water retention in heart failure and diuretic therapy: basic mechanisms

1 reference

12 December 2020

Incidence and prevalence of hyponatremia

1 reference

12 December 2020

Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia

1 reference

12 December 2020

Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry

1 reference

12 December 2020

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial

1 reference

12 December 2020

Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials

1 reference

12 December 2020

Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial

1 reference

12 December 2020

Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia

1 reference

12 December 2020

Characterization and Prognostic Value of Persistent Hyponatremia in Patients With Severe Heart Failure in the ESCAPE Trial

1 reference

12 December 2020

Hyponatraemia in acute heart failure is a marker of increased mortality but not when associated with hyperglycaemia

1 reference

12 December 2020

Efficacy and safety of the vasopressin V1A/V2-receptor antagonist conivaptan in acute decompensated heart failure: a dose-ranging pilot study

1 reference

12 December 2020

Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial

1 reference

12 December 2020

Long-term outcome after a first episode of heart failure. A prospective 7-year study

1 reference

12 December 2020

Relation of serum sodium level to long-term outcome after a first hospitalization for heart failure with preserved ejection fraction

1 reference

12 December 2020

Chronic systolic heart failure, guideline-directed medical therapy, and systemic hypotension-less pressure but maybe more risk (does this clinical scenario need more discussion?)

1 reference

12 December 2020

Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial.

1 reference

12 December 2020

The treatment of hyponatremia

1 reference

12 December 2020

Effects of tolvaptan on dyspnoea relief from the EVEREST trials

1 reference

12 December 2020

Nonosmolar factors affecting renal water excretion (first of two parts).

1 reference

12 December 2020

Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure

1 reference

12 December 2020

Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin

1 reference

12 December 2020

Clinical aspects and pathophysiology of diuretic-induced hyponatremia.

1 reference

12 December 2020

Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective

1 reference

12 December 2020

Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients

1 reference

12 December 2020

Therapeutic recommendations for management of severe hyponatremia: current concepts on pathogenesis and prevention of neurologic complications

1 reference

12 December 2020

Identifiers

DOI

10.1002/CLC.20822

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653540&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653540&resulttype=core&format=json

15 May 2020

1 reference